跳至主要内容
ProhibitedBinding ruleSAOriginal is English已检查官方来源导入

[Oxalylbis(iminoethylene)]bis[(o-chlorobenzyl)diethylammonium] salts, e.g. ambenonium chloride (INN)

Listed by the Saudi Food and Drug Authority as prohibited in cosmetic products.

监管决定及完整条件

状态
Prohibited
法律地位
Binding rule
监管摘要
Listed by the Saudi Food and Drug Authority as prohibited in cosmetic products.
条件与限制
A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. 请打开所引用的来源,并适用下方的全市场要求。

物质身份

官方来源名称
[Oxalylbis(iminoethylene)]bis[(o-chlorobenzyl)diethylammonium] salts, e.g. ambenonium chloride (INN)
CAS
115-79-7
EC
Not supplied in this source row
身份映射
standalone:official_sfda_record

该身份的跨市场概览

本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。

9 个市场数据集
CAS 115-79-7 的 PubChem 二维化学结构
CAS 115-79-7PubChem CID 8288

CAS 115-79-7 的已核实化学信息

Ambenonium Chloride

Ambenonium chloride is a symmetrical oxalamide-based bis-quaternary ammonium salt having ethyl and 2-chlorobenzyl groups attached to the nitrogens. It has a role as a neurotransmitter agent and an EC 3.1.1.8 (cholinesterase) inhibitor. It is a quaternary ammonium salt and an organic chloride salt. — ChEBI

IUPAC 名称
(2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethylazaniumyl]ethylamino]-2-oxoacetyl]amino]ethyl]-diethylazanium dichloride
分子式
C28H42Cl4N4O2
分子量
608.5 g/mol
精确质量
608.203237 Da
单同位素质量
606.206187 Da
拓扑极性表面积
58.2 Ų
分子复杂度
614.0
形式电荷
0
氢键供体
2
氢键受体
4
可旋转键
14
重原子
38
共价单元
3

向 PubChem 报告的名称和同义词

MytelaseAmbenonii chloridumAmbestigmin chlorideOxazylumMisuranOxazylCloruro de ambenonioChlorure d'ambenonium
另有 16 个已报告名称
Win 807751FOB87G3IN,N'-Bis(2-diethylaminoethyl)oxamide bis(2-chlorobenzyl chloride)(Oxalylbis(iminoethylene))bis((o-chlorobenzyl)diethylammonium) dichlorideCHEBI:2628Benzenemethanaminium, N,N'-((1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl))bis(2-chloro-N,N-diethyl-, dichlorideChloride, Ambenonium[Oxalylbis(iminoethylene)]bis[(O-chlorobenzyl)diethylammonium] dichlorideambAnonium (cation)RefChem:57385Benzenemethanaminium, N,N'-((1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl))bis(2-chloro-N,N-diethyl)-, dichlorideN07AA30(Oxalylbis(iminoethylene))bis((o-chlorobenzyl)diethyl-ammonium), Dichloride2,2'-((1,2-Dioxoethane-1,2-diyl)diimino)bis(N-(2-chlorobenzyl)-N,N-diethylethylaminium) dichloride204-107-5N,N'-((1,2-Dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl))bis(2-chloro-N,N-diethyl-benzenemethanaminium), Dichloride
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl.[Cl-].[Cl-]
InChI
InChI=1S/C28H40Cl2N4O2.2ClH/c1-5-33(6-2,21-23-13-9-11-15-25(23)29)19-17-31-27(35)28(36)32-18-20-34(7-3,8-4)22-24-14-10-12-16-26(24)30;;/h9-16H,5-8,17-22H2,1-4H3;2*1H
InChIKey
DXUUXWKFVDVHIK-UHFFFAOYSA-N

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配8288

Attributed physical-property, hazard, environmental and use annotations.

  • Signal: Danger 来源: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H300 (100%): Fatal if swallowed [Danger Acute toxicity, oral] 来源: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
  • Health Effects: Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, incre 来源: Toxin and Toxin Target Database (T3DB)
  • Toxicity Summary: Ambenonium is a cholinesterase or acetylcholinesterase (AChE) inhibitor. A cholinesterase inhibitor (or 'anticholinesterase') suppresses the action of acetylcholinesterase. Because of its essential function, chemicals that interfere with the action of acetylcholinesterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses, followed by muscle spasms and ultimately death. Nerve gases and many substances used in insecticides have been shown to act by binding a serine in the active site of acetylcholine esterase, inhibiting the enzyme completely. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop. Among the most common acetylcholinesterase inhibitors are phosphorus-based compounds, which are designed to bind to the active site of the enzyme. The structural requirements are a phosphorus atom bearing two lipophilic groups, a leaving group (such as a hal 来源: Toxin and Toxin Target Database (T3DB)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

官方来源与出处

已登记来源
Saudi SFDA prohibited and restricted ingredient lists
来源参考
SFDA prohibited list, page 14, row 4
来源记录 ID
prohibited-13-4
来源版本
live-snapshot-2026-08-30
来源语言
English
翻译状态
Original is English
快照检查时间
2026-08-30 05:18 UTC
验证方法
complete SFDA paginated HTML snapshot; strict page/row counts
SHA-256
ceb6cc636e6b1f4b3013f88ce0297217b49d6194342c6ece5c03b1e04256d71a

已登记的数据集备注

数据集覆盖范围
Prohibited and restricted substances with CAS, EC and conditions
权威性说明
Official SFDA dated lists; version and hash each release

本记录在市场数据集中的位置

2090
条当前 Saudi Arabia 记录
1726
条标记为 Prohibited 的记录
2090
条来自此来源版本的记录
1991
条带有 CAS 身份的市场记录

状态分布

在 2090 条当前记录中,有 0 条带有条件文本。条件字段为空时,按上述记录类型解释;绝不会被转换为可无限制使用的声明。

Saudi Arabia 市场背景

Complete official list index

覆盖版本: SFDA live prohibited/restricted lists, snapshot 30 August 2026

Every page and entry in the public SFDA prohibited and restricted ingredient indexes; restricted detail pages remain the source for conditions.

核实清单

  1. Search names and CAS across both SFDA lists.
  2. Open the cited restricted-entry detail and apply every condition.
  3. Check current SFDA/GSO technical regulations and updates.
  4. Complete eCosma notification, label and responsible-party requirements.

官方市场来源

核实工作流程与记录完整性

在将此结果用于合规决定之前

  1. 确认“[Oxalylbis(iminoethylene)]bis[(o-chlorobenzyl)diethylammonium] salts, e.g. ambenonium chloride (INN)”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
  2. Search names and CAS across both SFDA lists.
  3. Open the cited restricted-entry detail and apply every condition.
  4. Check current SFDA/GSO technical regulations and updates.
  5. Complete eCosma notification, label and responsible-party requirements.
  6. 记录来源版本,并在生产、备案或上市之前重新核查监管机构。

本记录中的可用字段

  • 官方物质名称可用
  • CAS可用
  • EC未提供
  • 单独的条件文本来源行中不存在
  • 生效日期未提供
  • 快照哈希与方法可用

本页回答的问题

This official record identifies the substance as prohibited for cosmetic use in the stated market scope. Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.

该记录引用 SFDA prohibited list, page 14, row 4,来源版本 live-snapshot-2026-08-30。 打开官方来源。

不保证。CAS 有助于确定身份,但各辖区可能对同一物质作出不同分类,并可能适用不同的产品范围、限值、警示语和过渡日期。

稳定引用

[Oxalylbis(iminoethylene)]bis[(o-chlorobenzyl)diethylammonium] salts, e.g. ambenonium chloride (INN). SFDA prohibited list, page 14, row 4. Saudi Arabia. Source version live-snapshot-2026-08-30. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/sa/records/9733/

请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。

Saudi Arabia 的解读与局限

This official record identifies the substance as prohibited for cosmetic use in the stated market scope.

Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

如何解读法律地位

The cited row forms part of a binding rule or legally incorporated list for this market.

本页证据

  • 记录结果:Prohibited
  • 法律地位:Binding rule
  • 来源版本:live-snapshot-2026-08-30

它不能证明什么

No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.

进一步的权威物质研究

这些来源均不能推翻上述市场决定。

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

在来源处研究此身份

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

在来源处研究此身份

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

在来源处研究此身份

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

在来源处研究此身份

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

在来源处研究此身份

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

在来源处研究此身份

US EPA CompTox CTX APIs

导入需要 API 密钥

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

在来源处研究此身份